GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer
- PMID: 29976479
- PMCID: PMC11167531
- DOI: 10.1016/j.ijrobp.2017.11.031
GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer
Comment on
-
Anorectal Function and Quality of Life in Patients With Early Stage Rectal Cancer Treated With Chemoradiation and Local Excision.Dis Colon Rectum. 2017 May;60(5):459-468. doi: 10.1097/DCR.0000000000000758. Dis Colon Rectum. 2017. PMID: 28383445 Free PMC article. Clinical Trial.
-
Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.Cancer. 2017 Aug 1;123(15):2909-2917. doi: 10.1002/cncr.30692. Epub 2017 Apr 6. Cancer. 2017. PMID: 28386965
-
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.Lancet. 2017 Jul 29;390(10093):469-479. doi: 10.1016/S0140-6736(17)31056-5. Epub 2017 Jun 7. Lancet. 2017. PMID: 28601342 Clinical Trial.
-
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.Eur J Cancer. 2017 Aug;81:183-190. doi: 10.1016/j.ejca.2017.04.027. Eur J Cancer. 2017. PMID: 28628843 Clinical Trial.
-
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
-
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.Lancet Oncol. 2017 Oct;18(10):1348-1359. doi: 10.1016/S1470-2045(17)30456-4. Epub 2017 Aug 9. Lancet Oncol. 2017. PMID: 28802802
References
-
- Wasan HS, Gibbs P, Sharma NK, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): A combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol 2017;18: 1159–1171. - PMC - PubMed
-
- Rullier E, Rouanet P, Tuech JJ, et al. Organ preservation for rectal cancer (GRECCAR 2): A prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 2017;390:469–479. - PubMed
-
- Stahl M, Walz MK, Riera-Knorrenschild J, et al. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial. Eur J Cancer 2017;81: 183–190. - PubMed
-
- Fitzgerald TL, Efird JT, Bellamy N, et al. Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients. Cancer 2017;123:2909–2917. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
